Search research articles
Contact Us
Filters
Showing results (131-140 of 368) with videos related to
Page
of 37
Sort By:
Journal of Vascular and Interventional Radiology : JVIR
|
June 18, 2021
Percutaneous Image-Guided Thermal Ablation of Adrenal Metastasis from Melanoma: A Single-Institution Experience
Samuel Jang, Patrick W Eiken, Thomas D Atwell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 4, 2018
Rheumatic Syndromes Associated With Immune Checkpoint Inhibitors: A Single-Center Cohort of Sixty-One Patients
Michael D Richter, Cynthia Crowson, Lisa A Kottschade, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
August 6, 2014
Fetal sex-based differences in maternal hormones, angiogenic factors, and immune mediators during pregnancy and the postpartum period
Elizabeth Ann L Enninga, Wendy K Nevala, Douglas J Creedon, et al.
Melanoma Research
|
July 26, 2016
Galectin-9 modulates immunity by promoting Th2/M2 differentiation and impacts survival in patients with metastatic melanoma
Elizabeth Ann L Enninga, Wendy K Nevala, Shernan G Holtan, et al.
International Wound Journal
|
March 25, 2025
Assessing the Safety, Tolerability and Efficacy of Cell-Free Amniotic Fluid in the Treatment of Non-Healing Venous Ulcers: Initial Experience From a Prospective, Multicenter, Phase II Study
Frederick Ditmars, Sarah E Ducharme, Aliza M Lee, et al.
International Journal of Dermatology
|
May 31, 2024
Granulomatous tattoo reaction associated with BRAF/MEK inhibitor therapy for metastatic melanoma
Nasro A Isaq, Sion W Jasmine, Margot S Peters, et al.
International Journal of Epidemiology
|
August 1, 1994
Adequacy of a single visit for classification of hypertensive status in a Nigerian civil servant population
N Markovic, I N Olomu, C H Bunker, et al.
Melanoma Research
|
December 7, 2018
A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1
Matthew S Block, Wendy K Nevala, Yuan-Ping Pang, et al.
Mayo Clinic Proceedings
|
June 11, 2017
Scleroderma Induced by Pembrolizumab: A Case Series
Naiara S Barbosa, David A Wetter, Carilyn N Wieland, et al.
Frontiers in Immunology
|
August 14, 2018
Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy
Yiyi Yan, Anagha Bangalore Kumar, Heidi Finnes, et al.
Page
of 37
Search research articles
Search
Showing results (131-140 of 368) with videos related to
Sort By:
Page
of 37
Journal of Vascular and Interventional Radiology : JVIR
|
June 18, 2021
Percutaneous Image-Guided Thermal Ablation of Adrenal Metastasis from Melanoma: A Single-Institution Experience
Samuel Jang, Patrick W Eiken, Thomas D Atwell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 4, 2018
Rheumatic Syndromes Associated With Immune Checkpoint Inhibitors: A Single-Center Cohort of Sixty-One Patients
Michael D Richter, Cynthia Crowson, Lisa A Kottschade, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
August 6, 2014
Fetal sex-based differences in maternal hormones, angiogenic factors, and immune mediators during pregnancy and the postpartum period
Elizabeth Ann L Enninga, Wendy K Nevala, Douglas J Creedon, et al.
Melanoma Research
|
July 26, 2016
Galectin-9 modulates immunity by promoting Th2/M2 differentiation and impacts survival in patients with metastatic melanoma
Elizabeth Ann L Enninga, Wendy K Nevala, Shernan G Holtan, et al.
International Wound Journal
|
March 25, 2025
Assessing the Safety, Tolerability and Efficacy of Cell-Free Amniotic Fluid in the Treatment of Non-Healing Venous Ulcers: Initial Experience From a Prospective, Multicenter, Phase II Study
Frederick Ditmars, Sarah E Ducharme, Aliza M Lee, et al.
International Journal of Dermatology
|
May 31, 2024
Granulomatous tattoo reaction associated with BRAF/MEK inhibitor therapy for metastatic melanoma
Nasro A Isaq, Sion W Jasmine, Margot S Peters, et al.
International Journal of Epidemiology
|
August 1, 1994
Adequacy of a single visit for classification of hypertensive status in a Nigerian civil servant population
N Markovic, I N Olomu, C H Bunker, et al.
Melanoma Research
|
December 7, 2018
A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1
Matthew S Block, Wendy K Nevala, Yuan-Ping Pang, et al.
Mayo Clinic Proceedings
|
June 11, 2017
Scleroderma Induced by Pembrolizumab: A Case Series
Naiara S Barbosa, David A Wetter, Carilyn N Wieland, et al.
Frontiers in Immunology
|
August 14, 2018
Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy
Yiyi Yan, Anagha Bangalore Kumar, Heidi Finnes, et al.
Page
of 37